We strive to ensure every patient is accessible to quality healthcare by investing 3% of our annual turnover in research and development. We have succeeded in developing innovative formulations and delivery systems, such as pre-filled syringe & metered-dose inhaler.
Our team is in constant pursuit for perfection to deliver quality, safety and efficacy of pharmaceutical products to your door step.
Kotra Pharma has 208 products registered with National Pharmaceutical Regulatory Agency (NPRA). All manufactured products comply to international standards of Good Manufacturing Practice (GMP), Pharmaceutical Inspection Convention / Scheme (PIC/S). We are also certified with UKAS ISO9001:2000. To enhance the process of pharmaceutical development, we are adopting QbD (quality by design) concept. Quality by Design (QbD) is a systematic approach for development and manufacturing. It is meant to ensure that the intended performance of a final drug product is as expected, both in terms of purity and efficacy.
Kotra Pharma believes that no details are too small to escape attention and innovate for better healthcare.
Our pipeline of innovations are to improve unmet pharmaceutical needs in three key areas:
1. Dosage form to improve drug delivery system
2. Formulation to improve drug stability
3. Dispensing to improve compliance
These innovations are applied to strengtern our product portfolio in Axcel Paediatric Care, Axcel/Vaxcel Anti-Infective, Axcel Dermatology Care and Axcel/Vaxcel Gastroenterology. We are also expanding our capabilities in new areas, such oncology in near future.
We are proud to be the pioneer in developing and manufacturing of Metered Dose Inhaler (MDI) line and Pre-Filled Syringe (PFS) in Malaysia.
Collaboration and licensing agreements are an indispensable business strategy for pharmaceutical companies in developing novel therapeutics.
We’re interested in working with a wide range of partners, in all phases of scientific and technical development throughout the world, including:
• Biotechnology or pharmaceutical companies
• Academic Researchers and Institutions
• Innovators in Healthcare Services or Technologies
We have a dedicated business development team to evaluate and execute acquisitions, partnerships, in-licensing and out-licensing in Primary Care, Specialty Care, Emerging Markets, Established Products, Diversified Businesses and Research & Development.
We welcome opportunities for collaboration in all phases and areas of scientific and technical development including, but not limited to:
• Biologics
• Vaccines
• Small Molecules
Kotra Pharma believes in evidence based medicines. We have initiated various clinical trials throughout the years, including but not limited to bioequivalent trials, post marketing trials and investigative study on nutritional impact for medically compromised patient. We have collaborated with both local & overseas universities and clinical research centres.
